Pergolide

Pergolide is a drug that has a stimulating effect on dopamine receptors in the brain. It is used to treat parkinsonism and is administered orally.

Possible side effects when taking pergolide include: confusion, hallucinations, drowsiness, abnormal heart rhythms, nausea, difficulty breathing, and double vision.

Pergolide is available in tablet form under the trade name Celancc. This drug helps replenish the lack of dopamine in patients with Parkinson's disease, reducing symptoms of the disease such as tremors, stiffness and slowness of movement.



Pergolide is a medicinal substance that has a stimulating effect on dopamine receptors located in the brain; used to treat parkinsonism. Prescribed internally. Possible side effects: confusion, hallucinations, drowsiness, heart rhythm disturbances, nausea, difficulty breathing and double vision. Trade name: Celancc.



Pergolido is a centrally acting medicinal substance found in the molecular form of ergot. It stimulates dopaminergic function receptors located in the nerve cells of the brain. It is valued by patients for its effectiveness, ease of use, low number and availability of side effects. Can be prescribed for the treatment of Parkinson's; it is administered orally, as lozenges, to be taken orally before meals. Pergolide has a number of side effects. This can cause confusion, hallucinations, constipation, or excessive sweating. There is also a high probability of problems with controlling eating behavior, excessive sleepiness, and increased irritability. Less commonly, it can cause low blood pressure, chest pain, slow heart rate, and exacerbation of cardiac arrhythmias. Often, pergoleader can cause breathing problems, coughing, sometimes with sputum, shortness of breath, dizziness, double vision, and tightening of the intestinal or stomach muscles. Occasionally, this group of substances provokes fever and skin diseases. Side effects do not always appear, but they never go away on their own.



Hello! Today, scientists are actively searching for cures for Parkinson's disease, which was named after the English physician James Parkinson. For several centuries, doctors have tried to develop drugs against this disease, but the attempts ended in failure. Dopamine was discovered relatively recently and was only proven effective in treating Parkinson's disease in the 1980s.

Pergolide is a stimulant of dopamine receptors in the brain. It is used to treat Parkinson's disease, as dopamine is involved in the regulation of motor activity and post-stroke rehabilitation. By chemical structure